Drug Type Cell therapy |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Celloram, Inc.Startup |
Active Organization Celloram, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Graft Rejection | Preclinical | US | Celloram, Inc.Startup | 02 Aug 2023 |
Graft vs Host Disease | Preclinical | US | Celloram, Inc.Startup | 02 Aug 2023 |